| scholarly article | Q13442814 |
| P50 | author | Theresa A Guise | Q63214862 |
| P2093 | author name string | Gregory R Mundy | |
| Wolfgang E Gallwitz | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine | Q28339382 | ||
| Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors | Q28359872 | ||
| Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia | Q33740366 | ||
| Use of bisphosphonates for the treatment of bone metastasis in experimental animal models | Q33764008 | ||
| Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma | Q33970512 | ||
| Cancer and bone | Q34066060 | ||
| Breast tumor cell lines from pleural effusions | Q34209613 | ||
| Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo | Q34224284 | ||
| Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol | Q34249259 | ||
| Parathyroid hormone related protein and hypercalcaemia in breast cancer | Q35181836 | ||
| Glucocorticoids in cancer therapy | Q35900526 | ||
| Transforming growth factor beta secretion from primary breast cancer fibroblasts | Q36691246 | ||
| Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis | Q37360238 | ||
| Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia | Q67895335 | ||
| Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control | Q67907340 | ||
| TGF alpha and TGF beta expression in mammary carcinoma | Q70464401 | ||
| Purification of estrogen receptors from MCF-7 human breast cancer cells | Q71356073 | ||
| Bisphosphonates in the treatment of bone diseases | Q71833485 | ||
| Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group | Q71890854 | ||
| Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo | Q71940236 | ||
| Multicentre study on intensified remission induction therapy for acute myeloid leukemia | Q72062106 | ||
| Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases | Q72559438 | ||
| The management of cancer metastatic to bone | Q72734178 | ||
| Regulation of parathyroid hormone-related peptide production in normal human mammary epithelial cells in vitro | Q72761780 | ||
| Comparative study of available medical therapy for hypercalcemia of malignancy | Q72778547 | ||
| Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study | Q73132141 | ||
| Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials | Q73504275 | ||
| Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases | Q73977301 | ||
| Reduction in new metastases in breast cancer with adjuvant clodronate treatment | Q74837359 | ||
| Bisphosphonates as anticancer drugs | Q74837390 | ||
| Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. | Q39390570 | ||
| Strontium 89 therapy for the palliation of pain due to osseous metastases | Q39472788 | ||
| Radionuclide-targeted therapy for the management of metastatic bone pain | Q40487242 | ||
| Parathyroid hormone-related protein and bone metastases | Q41080338 | ||
| Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein | Q41211109 | ||
| Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice | Q41256474 | ||
| Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice | Q41312059 | ||
| Effects of transforming growth factor-beta on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro | Q41462925 | ||
| The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro | Q41544959 | ||
| Transforming growth factor beta stimulation of parathyroid hormone-related protein (PTHrP): a paracrine regulator? | Q41568691 | ||
| Parathyroid hormone-like peptide shares features with members of the early response gene family: rapid induction by serum, growth factors, and cycloheximide. | Q41621097 | ||
| Stimulation by parathyroid hormone-related protein and transforming growth factor-α of phosphate transport in osteoblast-like cells | Q41659264 | ||
| Effect of transforming growth factor-alpha and parathyroid hormone-related protein on phosphate transport in renal cells | Q41712435 | ||
| Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma | Q41739974 | ||
| Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites | Q41761675 | ||
| Establishment and characterization of three new continuous cell lines derived from human breast carcinomas | Q42802314 | ||
| Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization | Q44058433 | ||
| Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer | Q46282102 | ||
| Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo | Q46292460 | ||
| IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. | Q50903728 | ||
| The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases | Q58008706 | ||
| Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line | Q59601015 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1559-1572 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo | |
| P478 | volume | 110 |
| Q39484426 | 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2. |
| Q91813806 | Advances in personalized treatment of metastatic spine disease |
| Q28742851 | Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone |
| Q27693653 | Biology of bone metastases |
| Q38053396 | Bone marrow microenvironment in cancer patients: immunological aspects and clinical implications |
| Q40168326 | Bone metastasis: can osteoclasts be excluded? |
| Q30437441 | Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy |
| Q35609713 | Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors |
| Q54348724 | Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. |
| Q37905720 | Contribution of bone tissue modulus to breast cancer metastasis to bone |
| Q37679939 | DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis |
| Q27303597 | Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ |
| Q35976870 | Endothelin-1 and osteoblastic metastasis |
| Q34152023 | Examining the Metastatic Niche: Targeting the Microenvironment |
| Q42132237 | HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition |
| Q37684506 | Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma |
| Q35603135 | Homing of cancer cells to the bone |
| Q46405799 | Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages |
| Q34284100 | Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction |
| Q34826767 | Manipulating the environment of cancer cells in bone: a novel therapeutic approach |
| Q36533587 | Metastatic bone cancer pain: etiology and treatment options |
| Q35110762 | Molecular pathology of tumor metastasis III. Target array and combinatorial therapies |
| Q33705984 | PTHrP gene expression in cancer: do all paths lead to Ets? |
| Q46053535 | Parathyroid hormone-related protein expression is correlated with clinical course in patients with glial tumors |
| Q37441564 | Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. |
| Q27023929 | Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis |
| Q39798725 | Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein |
| Q34796551 | TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling |
| Q37438290 | The role of the calcium-sensing receptor in bone biology and pathophysiology |
| Q30311918 | Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone Metastases |
| Q34644776 | Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer |
Search more.